These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9328808)

  • 21. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
    Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
    J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulant abuse treatment as HIV prevention.
    Shoptaw S; Reback CJ; Frosch DL; Rawson RA
    J Addict Dis; 1998; 17(4):19-32. PubMed ID: 9848029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
    Elkashef A; Rawson RA; Smith E; Pearce V; Flammino F; Campbell J; Donovick R; Gorodetzky C; Haning W; Mawhinney J; McCann M; Weis D; Williams L; Ling W; Vocci F
    Addiction; 2007 Apr; 102 Suppl 1():107-13. PubMed ID: 17493059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methamphetamine abuse and emergency department utilization.
    Richards JR; Bretz SW; Johnson EB; Turnipseed SD; Brofeldt BT; Derlet RW
    West J Med; 1999 Apr; 170(4):198-202. PubMed ID: 10344172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subjective responses to initial experience with cocaine: an exploration of the incentive-sensitization theory of drug abuse.
    Lambert NM; McLeod M; Schenk S
    Addiction; 2006 May; 101(5):713-25. PubMed ID: 16669905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment response by primary drug of abuse: does methamphetamine make a difference?
    Luchansky B; Krupski A; Stark K
    J Subst Abuse Treat; 2007 Jan; 32(1):89-96. PubMed ID: 17175402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meth mouth: a review of methamphetamine abuse and its oral manifestations.
    Curtis EK
    Gen Dent; 2006; 54(2):125-9; quiz 130. PubMed ID: 16689071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular mechanism for methamphetamine-induced memory impairment].
    Nagai T; Yamada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Apr; 45(2):81-91. PubMed ID: 20486560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why do we need an Addiction supplement focused on methamphetamine?
    Rawson RA; Condon TP
    Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users.
    Kim DJ; Roh S; Kim Y; Yoon SJ; Lee HK; Han CS; Kim YK
    Neurosci Lett; 2005 Nov; 388(2):112-5. PubMed ID: 16039058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine abuse: medical and dental considerations.
    Smart RJ; Rosenberg M
    J Mass Dent Soc; 2005; 54(2):44-6, 48-9. PubMed ID: 16149403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
    National Toxicology Program
    NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Explanations for methamphetamine use among gay and bisexual men in New York City.
    Halkitis PN; Fischgrund BN; Parsons JT
    Subst Use Misuse; 2005; 40(9-10):1331-45. PubMed ID: 16048820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological differences between binge and chronic methamphetamine using gay and bisexual men.
    Halkitis PN; Shrem MT
    Addict Behav; 2006 Mar; 31(3):549-52. PubMed ID: 15967585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nature, time course and severity of methamphetamine withdrawal.
    McGregor C; Srisurapanont M; Jittiwutikarn J; Laobhripatr S; Wongtan T; White JM
    Addiction; 2005 Sep; 100(9):1320-9. PubMed ID: 16128721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methamphetamine use by incarcerated women: comorbid mood and anxiety problems.
    Vik PW
    Womens Health Issues; 2007; 17(4):256-63. PubMed ID: 17544297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.